Sickle Cell Disease and Hematopoietic Stem Cell Transplantation , 1st ed. 2018
Coordonnateurs : Meier Emily Riehm, Abraham Allistair, Fasano Ross M.
Part I Sickle Cell Disease
1. Clinical Manifestations of Sickle Cell Disease Across the Lifespan
Lydia H. Pecker, Jane Little
2. Pathobiology of Sickle Cell Disease Vaso-Occlusion and Targeted Therapies
Kerry A. Morrone, Jennifer Davila, W. Beau Mitchell, Deepa Manwani
3. Current Non-HSCT Related Treatments for SCD
Claire L. Anderson, Deepika S. Darbari
4. Risk Based Therapies for Sickle Cell Disease
Emily R. Meier
5. Transfusion Support of the Patient with Sickle Cell Disease Undergoing Transplantation
Jeanne E. Hendrickson, Ross M. Fasano
6. Neurological Manifestations of Sickle Cell Disease and Their Impact on Allogeneic Hematopoietic Stem Cell Transplantation
Jessica Carpenter, Monica L. Hulbert
Part II Hematopoietic Stem Cell Transplantation
7. Overview of Hematopoietic Stem Cell Transplantation for Non-Malignant Diseases
Karen L Zimowski, Shanmuganathan Chandrakasan
8. Unique Challenges of Hematopoietic Stem Cell Transplant for Sickle Cell Disease
Pooja Khandelwal, Michael Grimley
9. The Ethics of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease
Robert Sheppard Nickel, Naynesh Kamani
10. Psychosocial Care and Education of Children with Sickle Cell Disease undergoing Hematopoietic Stem Cell Transplant and their Families
Steven J. Hardy, Jasmine Holt, Amanda L. Thompson
11. Long Term Effects of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease
Karim T. Sadak, Angela R. Smith, Monica Bhatia
12. Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease
Gregory M.T. Guilcher, John T. Horan
13. Unrelated Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease
Alexander Ngwube, Shalini Shenoy
14. Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease
Elizabeth O. Stenger, Allistair Abraham
15. Gene Therapy 101: The Path Toward Becoming a Realistic Cure for Patients with Sickle Cell Disease
Alexis Leonard, Allistair Abraham
Outlines the unique challenges of HSCT and profiles supportive care guidelines for patients with SCD
Reviews several landmark phase III trials that utilize matched unrelated and haploidentical donors for HSCT in SCD patients
Written by experts in the field
Includes supplementary material: sn.pub/extras
Date de parution : 08-2018
Ouvrage de 334 p.
15.5x23.5 cm
Date de parution : 10-2017
Ouvrage de 334 p.
15.5x23.5 cm